Elite in Peripheral Neuropathy

Dinesh Selvarajah

Sheffield, ENG, GB 
Elite in Peripheral Neuropathy
Sheffield, ENG, GB 
OverviewLocationsClinical Research

Overview

Dinesh Selvarajah practices in Sheffield, United Kingdom. Mr. Selvarajah is rated as an Elite expert by MediFind in the treatment of Peripheral Neuropathy. His top areas of expertise are Diabetic Neuropathy, Peripheral Neuropathy, Neuralgia, and Autonomic Neuropathy.

His clinical research consists of co-authoring 53 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 20 articles in the study of Peripheral Neuropathy.

Gender
Male

Locations

Sheffield, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2 Placebo-Controlled, Double-Blind, Enriched Enrollment Randomized Withdrawal Study to Evaluate the Efficacy and Safety of BIIB074 (Vixotrigine) in Treating Pain Experienced by Subjects With Confirmed Small Fiber Neuropathy That is Idiopathic or Associated With Diabetes Mellitus
A Phase 2 Placebo-Controlled, Double-Blind, Enriched Enrollment Randomized Withdrawal Study to Evaluate the Efficacy and Safety of BIIB074 (Vixotrigine) in Treating Pain Experienced by Subjects With Confirmed Small Fiber Neuropathy That is Idiopathic or Associated With Diabetes Mellitus
Enrollment Status: Terminated
Publish Date: May 05, 2021
Intervention Type: Drug
Study Drug: BIIB074
Study Phase: Phase 2

53 Total Publications

High glucose mediates diabetic peripheral neuropathy by inducing Schwann cells apoptosis through the Dgkh/PKC-α signaling pathway.
High glucose mediates diabetic peripheral neuropathy by inducing Schwann cells apoptosis through the Dgkh/PKC-α signaling pathway.
Journal: Acta diabetologica
Published: February 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Selvarajah's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile